Ukraine’s Health Ministry has signed a medicine procurement agreement with Britain’s Crown Agents to use 2016 budget funds. Crown Agents reported that the agreement was signed on October 27. Soon it would be specified under what programs and what cost of the procurement would be. On November 6, 2015 the agency signed a contract with…
Ukraine’s biggest pharmaceutical company Indar plans to build a medicine plant in Azerbaijan, Ukrainian Ambassador to Azerbaijan Alexander Mishchenko said. He made the remarks on October 20,during a tourism forum in Baku. Mishchenko noted that the company was in negotiations in Azerbaijan and the share in the enterprise would be divided 50-50. (Trend/Business World Magazine)
Belarus and India are working hard to advance cooperation in pharmaceutics, the Chairman of the Council of the Republic of the National Assembly of Belarus Mikhail Myasnikovich reported. The senator took part in the festivities timed to the opening of a research center of the pharmaceutical company SOOO Nativita in Beshenkovichi, Vitebsk region. Speaking about…
Ukrainian pharmaceutical company Farmak plans to register its products in Malaysia by late 2018, Farmak Business Development Director Oleh Siarkevych reported. He said that first the company intended to bring its strategic products to new markets, in particular, insulin and Amizonum created by the company. In addition, the company plans to offer its ophthalmological portfolio…
The state could support Ukrainian pharmaceutical manufacturers by creating equally competitive conditions with foreign manufacturers, Deputy Health Minister Roman Ilyk has said. “There is no secret that in other countries the state supports pharmaceutical manufacturers, directly investing funds and making orders. There is no such possibility in Ukraine. We can create equally competitive conditions so…
Britain’s Crown Agents will not be able to supply three out of 214 pharmaceuticals from the procurement list bought using 2015 national budget funds. There is no alternative to the drugs in Ukraine today. Crown Agents reported that Lamivudinum (1,200 mg, 69th on the list) would not be bought due to the impossibility of buying…
Arterium Corporation (Kyiv) has acquired Marifarm pharmaceutical company (Maribor, Slovenia) from Slovenian bank Nova KBM (NKBM). The bank has not disclosed the amount of the transaction. According to unofficial information from Maribor’s local edition Vecer, it is estimated at 6.8 million euro. Arterium and Marifarm intend to jointly explore new possibilities of development of pharmaceutical…